Effects of adding steroids, in vitro irradiation, or both to cyclosporine, immunosuppression in the murine laryngeal transplantation model

被引:8
作者
Lorenz, RR
Dan, O
Haug, M
Strome, M
机构
[1] Cleveland Clin Fdn, Dept Otolaryngol & Communicat Disorders, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Pharmacol, Cleveland, OH 44195 USA
关键词
cyclosporine; larynx; muridae; prednisone; radiation; steroids; trachea; transplantation; voice;
D O I
10.1177/000348940211100511
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Adding oral prednisone or in vitro organ irradiation to an immunosuppressive regimen for laryngeal transplantation may allow cyclosporine dosage to be decreased without compromising organ rejection rates. Using an established rat laryngeal transplant model, we sought to determine whether combined immunosuppressive regimens decreased rejection rates. Twenty-two treatment groups of 10 animals each were studied. Cyclosporine was administered at 2 different historically low dosages (1.5 and 2 mg/kg per day) alone, in combination with prednisone, and with in vitro irradiation of the harvested larynx. At 15 days after transplantation, cyclosporine combined with prednisone did not significantly alter the mean severity of rejection. At 30 days after transplantation, rats treated with a combination of cyclosporine 2 mg/kg and prednisone 1 mg/kg showed the least amount of rejection. Rejection rates were significantly higher with 2 mg/kg cyclosporine alone (p<.00024). Irradiation did not significantly decrease the severity of rejection. These results demonstrate that at 1 month after transplantation, a combined steroid and cyclosporine regimen reduces the severity of rejection after laryngeal transplantation in an animal model. Our findings suggest that laryngeal transplant patients may be treated with low cyclosporine doses without experiencing organ rejection if steroids are added to the immunosuppressive regimen.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 16 条
[1]   Effect of in vitro irradiation of donor larynges on cyclosporine requirements and rejection rates in rat laryngeal transplantation [J].
Barthel, SW ;
Dan, O ;
Myles, J ;
Strome, M .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2001, 110 (01) :20-24
[2]   BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J].
BOREL, JF ;
FEURER, C ;
GUBLER, HU ;
STAHELIN, H .
AGENTS AND ACTIONS, 1976, 6 (04) :468-475
[3]  
CALNE RY, 1978, LANCET, V2, P1323
[4]  
CANAFAX DM, 1983, CLIN PHARMACY, V2, P515
[5]  
FERGUSON RM, 1982, SURGERY, V92, P175
[6]   CARDIAC TRANSPLANTATION WITH CYCLOSPORIN-A AND PREDNISONE [J].
GRIFFITH, BP ;
HARDESTY, RL ;
DEEB, GM ;
STARZL, TE ;
BAHNSON, HT .
ANNALS OF SURGERY, 1982, 196 (03) :324-329
[7]  
KAHAN BD, 1989, NEW ENGL J MED, V321, P1725
[8]   SPARING OF SUPPRESSOR CELLS - A CRITICAL ACTION OF CYCLOSPORINE [J].
KUPIECWEGLINSKI, JW ;
FILHO, MA ;
STROM, TB ;
TILNEY, NL .
TRANSPLANTATION, 1984, 38 (02) :97-101
[9]   STABILITY OF RENAL-ALLOGRAFT FUNCTION ASSOCIATED WITH LONG-TERM CYCLOSPORINE IMMUNOSUPPRESSIVE THERAPY - 5 YEAR FOLLOW-UP [J].
LEWIS, RM ;
JANNEY, RP ;
GOLDEN, DL ;
KERR, NB ;
VANBUREN, CT ;
KERMAN, RH ;
KAHAN, BD .
TRANSPLANTATION, 1989, 47 (02) :266-272
[10]   Alloreactive delayed-type hypersensitivity in graft recipients - Complexity of responses and divergence from acute rejection [J].
Sirak, J ;
Orosz, CG ;
Wakely, E ;
VanBuskirk, AM .
TRANSPLANTATION, 1997, 63 (09) :1300-1307